The purpose of the project is to investigate exercise performance in humans following bronchodilation induced by acute inhalation of beta2-agonist vilanterol + fluticasone furoate
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Enrollment
30
Participants are administered 25 µg of vilanterol + fluticasone furoate
Participants are administered 100 µg of vilanterol + fluticasone furoate
Participants are administered placebo
August Krogh Building
Copenhagen, DK, Denmark
RECRUITINGPower output during sprint testing
Power output measured in Watts during a sprint on a bike ergometer
Time frame: Through study completion, an average of 3 weeks
Power output during time trial
Mean power output measured in Watts during a time trial on a bike ergometer
Time frame: Through study completion, an average of 3 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.